Filing Flows › Integrated Biopharma (INBP) › Free cash flow
Integrated Biopharma (INBP) free cash flow by quarter
Integrated Biopharma's free cash flow was $593K in Q2 FY26 (second quarter fiscal 2026), -47% from Q1 FY26. Over the last 4 quarters it ranged from $172K (Q2 FY25) to $1.1M (Q1 FY26).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q2 FY26 | $593K | -47% | +245% |
| Q1 FY26 | $1.1M | +126% | — |
| Q3 FY25 | $500K | +191% | — |
| Q2 FY25 | $172K | — | — |
Q2 FY26 at a glance
Integrated Biopharma, Q2 FY26: revenue $11.3M (-11% year over year), operating margin -8.1%, net loss $762K, operating cash flow $617K. The chart follows the revenue to costs, profit and cash.
Questions
What is Integrated Biopharma's free cash flow?
Integrated Biopharma's free cash flow was $593K in Q2 FY26 (second quarter fiscal 2026), -47% from Q1 FY26.
How has Integrated Biopharma's free cash flow changed?
Over the last 4 quarters it ranged from $172K (Q2 FY25) to $1.1M (Q1 FY26).